🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
4,720 results for “eu”
MedicineActive substanceLicence holderStatus
Voncento 250 IU/600 IU Powder and solvent for solution for injection/infusion
EU/1/13/857/001
Human coagulation factor viii, Von willebrand factor CSL Behring GmbH
Voncento 500 IU/1200 IU Powder and solvent for solution for injection/infusion
EU/1/13/857/002
Von willebrand factor, Human coagulation factor viii CSL Behring GmbH
Voncento 500 IU/1200 IU Powder and solvent for solution for injection/infusion
EU/1/13/857/003
Human coagulation factor viii, Von willebrand factor CSL Behring GmbH
Voquily 1 mg/ml oral solution
PA22757/001/001
Melatonin RAD Neurim Pharmaceuticals EEC SARL Not marketed
Voranigo 10 mg film-coated tablets
EU/1/25/1912/001
Vorasidenib hemicitrate hemihydrate Les Laboratoires Servier
Voranigo 40 mg film-coated tablets
EU/1/25/1912/002
Vorasidenib hemicitrate hemihydrate Les Laboratoires Servier
Voraxaze 1,000 units powder for solution for injection
EU/1/21/1586/001
Glucarpidase Serb S.A.S.
Voriconazole 200mg powder for solution for infusion
PA2059/020/001
Voriconazole Fresenius Kabi Deutschland GmbH Marketed
Voriconazole Accord 200 mg film-coated tablets
EU/1/13/835/010-018
Voriconazole Accord Healthcare S.L.U.
Voriconazole Accord 50 mg film-coated tablets
EU/1/13/835/001-009
Voriconazole Accord Healthcare S.L.U.
Voriconazole Hikma 200 mg powder for solution for infusion
EU/1/15/1004/001-002
Voriconazole Hikma Farmacêutica (Portugal) S.A.
Voriconazole Seacross 200 mg powder for solution for infusion
PA22766/009/001
Voriconazole Seacross Pharma (Europe) Limited Marketed
Vosevi 200 mg/50 mg/50 mg film-coated tablets
EU/1/17/1223/002
Sofosbuvir, Velpatasvir, Voxilaprevir Gilead Sciences Ireland UC
Vosevi 400 mg/100 mg/100 mg film-coated tablets
EU/1/17/1223/001
Sofosbuvir, Velpatasvir, Voxilaprevir Gilead Sciences Ireland UC
Votrient 200 mg Film-coated tablets
EU/1/10/628/001-2
Pazopanib hydrochloride Novartis Europharm Limited
Votrient 400 mg Film-coated tablets
EU/1/10/628/003-4
Pazopanib hydrochloride Novartis Europharm Limited
Votubia 10 mg Tablet
EU/1/11/710/006-007
Rad n bht Novartis Europharm Limited
Votubia 1mg Dispersible tablet
EU/1/11/710/016
Everolimus Novartis Europharm Limited
Votubia 2 mg Dispersible tablet
EU/1/11/710/009-011
Rad n bht Novartis Europharm Limited
Votubia 2.5 mg Tablet
EU/1/11/710/001-003
Rad n bht Novartis Europharm Limited
Votubia 3 mg Dispersible tablet
EU/1/11/710/012-013
Rad n bht Novartis Europharm Limited
Votubia 5 mg Dispersible tablet
EU/1/11/710/014-015
Rad n bht Novartis Europharm Limited
Votubia 5 mg Tablet
EU/1/11/710/004-005
Rad n bht Novartis Europharm Limited
Voxzogo 0.4 mg powder and solvent for solution for injection
EU/1/21/1577/001
Vosoritide Biomarin International Limited
Voxzogo 0.56 mg powder and solvent for solution for injection
EU/1/21/1577/002
Vosoritide Biomarin International Limited
Voxzogo 1.2 mg Powder and solvent for solution for injection
EU/1/21/1577/003
Vosoritide Biomarin International Limited
Voydeya 100 mg film-coated tablets
EU/1/24/1792/003-004
Danicopan Alexion Europe S.A.S.
Voydeya 50 mg + 100 mg film-coated tablets
EU/1/24/1792/001-002
Danicopan Alexion Europe S.A.S.
VPRIV 400 Units powder for solution for infusion
EU/1/10/646/002-006
Velaglucerase alfa Shire Pharmaceuticals Ireland Limited
Vueway 0.5 mmol/mL solution for injection
EU/1/23/1773/001-010
Gadopiclenol Bracco Imaging spa
Vumerity 231 mg gastro-resistant hard capsules
EU/1/21/1585/001-002
Diroximel Fumarate Biogen Netherlands B.V.
Vydura 75 mg oral lyophilisate
EU/1/22/1645/001-003
Rimegepant sulfate Pfizer Europe MA EEIG
VYEPTI 100 mg concentrate for solution for infusion
EU/1/21/1599/001
Eptinezumab H. Lundbeck A/S
VYEPTI 300 mg concentrate for solution for infusion
EU/1/21/1599/003
Eptinezumab H. Lundbeck A/S
Vyjuvek 5 x 10⁹ PFU/ml Suspension and gel for gel
EU/1/25/1918/001
Beremagene geperpavec Krystal Biotech Netherlands B.V.
Vyloy 100 mg powder for concentrate for solution for infusion.
EU/1/24/1856/001-002
Zolbetuximab Astellas Pharma Europe B.V.
Vyndaqel 61 mg soft capsules
EU/1/11/717/001
Tafamidis Pfizer Europe MA EEIG
Vyndaqel 61 mg soft capsules
EU/1/11/717/003-004
Tafamidis Pfizer Europe MA EEIG
Vysribli (previously known as Denosumab Intas) 60 mg solution for injection in pre-filled syringe
EU/1/25/1993/001
Denosumab Intas Third Party Sales 2005 S.L.
Vyvgart 1000 mg solution for injection
EU/1/22/1674/002
Efgartigimod ALFA Argenx
Vyvgart 20 mg/mL concentrate for solution for infusion
EU/1/22/1674/001
Efgartigimod ALFA Argenx
Vyxeos liposomal 44 mg/100 mg powder for concentrate for solution for infusion
EU/1/18/1308/001-003
Cytarabine, DAUNOMYCIN HYDROCHLORIDE Jazz Pharmaceuticals Ireland Limited
Wainzua 45 mg solution for injection in pre-filled pen
EU/1/24/1875/001
Eplontersen sodium AstraZeneca AB
Wakix 18 mg film-coated tablets
EU/1/15/1068/002
Pitolisant hydrochloride Bioprojet Pharma
Wakix 4.5 mg film-coated tablets
EU/1/15/1068/001
Pitolisant hydrochloride Bioprojet Pharma
Warfant 1 mg Tablets
PA0073/139/001
WARFARIN SODIUM Mercury Pharmaceuticals (Ireland) Ltd Marketed
Warfant 3 mg Tablets
PA0073/139/002
WARFARIN SODIUM Mercury Pharmaceuticals (Ireland) Ltd Marketed
Warfant 5 mg Tablets
PA0073/139/003
WARFARIN SODIUM Mercury Pharmaceuticals (Ireland) Ltd Marketed
Warfarin Teva 0.5 mg tablets
PA2050/001/001
Warfarin sodium clathrate Sun Pharmaceutical Industries Europe B.V. Marketed
Warfarin Teva 1 mg tablets
PA2050/001/002
Warfarin sodium clathrate Sun Pharmaceutical Industries Europe B.V. Marketed
86 87 88 89 90 91 92
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 16 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.